Abstract
Objective To investigate the clinical significance of the expression of Ll capsid protein in cervical lesion cells infected with human papillomavirus (HPV), for the prevention of cervical cancer and suggestion of progression and probability of potential lesions. Methods 259 different levels of cervical lesion patients were patients group, including 103 cases negative for intraepithelial lesion and malignancy (NILM), 91 cases with atypical squamous cells of undetermined significance(ASCUS), 36 cases with low-grade squamous intraepithelial lesion (LSIL), 23 cases with high-grade squamous intraepithelial lesion(HSIL), and 6 cases with squamous cell carcinoma (SCC). Cervical cell samples of 50 normal physical examination people were control group. Immunohistochemical staining for Ll capsid protein and PCR-based reverse blot hybridization for 23 HPV DNA were employed. Results Both Ll capsid protein detection and PCR -based reverse blot hybridization detection were negative in the control group.The infection ratio of HPV were 23.3%, 69.2%, 83.3%, 87.0% and 100% in woman with NILM, ASCUS, LSIL, HSIL and SCC, respectively. The constituent ratio of high-risk HPV (HR-HPV)were 79.2%, 92.1%, 96.7%, 100% and 100% in HPV positive patients with NILM, ASCUS, LSIL, HSIL and SCC, respectively. The positive rates of HPV Ll capsid protein in NILM, ASCUS, LSIL, HSIL and SCC were 25.2%, 31.9%, 63.8%, 17.4% and 0.0%, respectively. Conclusions Both infection ratio of HPV and constituent ratio of HR-HPV were increased gradually with the aggravation of cervical lesions, and the infection ratio of HPV and constituent ratio of HR-HPV were closely related to the degree of cervical diseases. The detection results of Ll capsid protein were on the rise in the early phase of cervical lesion, however, declining in the late phase of cervical lesion, the expression of HPV Ll capsid protein associates with the degrees of cervical lesion, which may serve as an indicator of cervical precancerous lesions of the follow-up. Key words: Papillomavirus, human; Ll capsid protein; Immunohistochemical staining; Cervical cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.